DENVER, January 21 /PRNewswire/ -- eTrinsic, a division of Simbionix USA Corporation (Simbionix), a developer of online medical education products and technology for training medical salespeople and professionals, today announced that Glen C. Williams joined the company as Sales Executive for the Midwest and Eastern Region. Glen will work out of a new office located in Grayslake, Illinois.
Glen brings strong experience in both eLearning technologies and medical procedures. His prior professional experience included selling customized and catalog eLearning programs, assessment tools and Learning Management Systems for manufacturers in the building materials industry. His medical background was gained while a medic in the United Sates Navy. Jacques Devaud, eTrinsic President stated, "We are pleased to have someone of Glen's caliber join our expanding US Sales organization to increase the coverage of the US Market."
Simbionix is a global leader in medical simulation technology. Simbionix mission is to provide state of the art, computer-assisted metrics-based surgical simulation systems, and set the standard for minimally invasive surgical training and performance.
Simbionix products provide medical experts with hands-on training in a comprehensive array of MIS procedures, including; GI Endoscopy, Endourology, percutaneous access, advanced laparoscopic procedures and Endovascular procedures. http://www.simbionix.com
eTrinsic develops clinically relevant e-learning content that incorporates interactive 3D graphics and level-I simulations. eTrinsic's products and services include custom course development, course modules and a content delivery platform. Together, these products serve the needs of many audiences, including sales representatives, physicians, clinicians and patients.
Contact: Jacques Devaud President, eTrinsic, a division of Simbionix USA 1422 Delgany Street, Suite 220 Denver , CO 80202 Direct: +1-303-381-2340 Mobile : +1-216-392-2195 Fax: +1-303-413-0251 email@example.com http://www.simbionix.com
Copyright©2009 PR Newswire.
All rights reserved